Yafo CEO Speaks at 19th Annual Biotech in Europe Forum

[Sept. 25, 2019, Basel] Sean Jiang, the CEO of Yafo Capital, participated 19th Annual Biotech in Europe Forum from 25th - 26th September 2019 at the Congress Center Basel, Switzerland. The forum provides access to an exciting cross-section of venture-funded and small-cap companies with leading investors and pharmas. Over 700 delegates and over 100 presenting companies, and 30+ pitches by seed companies have been involved.

Sean Jiang spoke at Partnering with Chinese Pharma & Biotech Companies Panel, with sharing his experiences regarding effective partnering with Chinese pharma companies. This panel discussed several topics include the current appetite and trends of Chinese companies in terms of drug licensing, deal making and negotiation process as well as deal structures, etc.

Sean Jiang speaks at 19th Annual Biotech in Europe Forum in Switzerland

The Panel is co-chaired by John Adamou, Vice President, Business Development, BeiGene Ltd. And Mirko Scherer, CEO, CoFeS China Ltd.

Panelists:

Marietta Wu, Managing Director of Quan Capital, Co-founder of Zai Lab Ltd.

Sean Jiang, CEO & Founder, Yafo Capital

Stephan Lensky, COO & CBO, EpimAb Biotherapeutics GmbH

Yuwen Liu, Founding Partner, BOHE Angel Fund

Shanghai Yafo Capital (www.yafocapital.com), as a boutique fund management and investment banking firm, specializes in cross-border private equity and M&A transactions. Headquartered in Shanghai, with offices in the US, Israel, Japan, and UK, Yafo Life Science is the healthcare arm under Yafo Capital, with a focus on global pharmaceutical and medical device companies that have a ‘China Angle’. Yafo Life Science is dedicated to bridge the global medical technologies and China market and capital.

For any inquires, please contact:

Ms. Qi Li

Email: info@yafocapital.com